This first systematic evaluation of actual delivered doses in VMAT-TBI confirms the technique's dosimetric precision and safety. Our findings provide actionable evidence for optimizing VMAT-TBI implementation in clinical practice, particularly regarding dose verification protocols and adaptive strategies for low-dose regimens.
Gao et al. (Sun,) studied this question.